INS and Hypoglycemia: Other algorithms were tested in outpatient settings, but with the use of remote monitoring25 or without a control arm.13,26 Remote monitoring and remote interventions at times of impending hypoglycemia could bias the study by underestimating hypoglycemia outcomes (hypoglycemia outcomes will be the result of the automated insulin delivery system plus the remote monitoring interventions).